7 Results for "

Modified MMAF

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Modified MMAF" in MCE Product Catalog:

Cat. No.: HY-156225
CAS No.: 745017-95-2
Purity:  99.83%
Target:  

ADC Payloads

Research Areas:  

Cancer

MMAF-OtBu (Example 2) is a modified MMAF (HY-15579 ). MMAF-OtBu can be used for synthesis of ADCs .
loading...
    loading...
Cat. No.: HY-139326
CAS No.: 1404073-19-3
Purity:  97.20%
NHS-MMAF is a modified MMAF extracted from patent WO2012143499, intermediat 219. MMAF is a potent tubulin polymerization inhibitor and is used as a antitumor agent
loading...
    loading...
Cat. No.: HY-128961
CAS No.: 1404071-64-2
Research Areas:  

Cancer

MC-Alkyl-Hydrazine Modified MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the Modified MMAF (a tubulin inhibitor), linked via the noncleavable MC-Alkyl-Hydrazine .
loading...
    loading...
Cat. No.: HY-141594
CAS No.: 1352202-47-1
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted research of cancer .
loading...
    loading...
Cat. No.: HY-139325
CAS No.: 1404073-10-4
Research Areas:  

Others

NHS-Modified MMAF (WO2012143499A2, intermediat 210) is an intermediate which can be used for producing the anti-mesothelin binder-agent conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-141593
CAS No.: 1404071-65-3
Research Areas:  

Cancer

Modified MMAF-C5-COOH is a agent-linker conjugate for ADC .
loading...
    loading...
Cat. No.: HY-139325A
Purity:  96.03%
Research Areas:  

Cancer

NHS-Modified MMAF (intermediat 210) TFA is an intermediate which can be used for producing the anti-mesothelin binder-agent conjugates (ADCs) .
loading...
    loading...